Article

The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam

2020-09-11

Abstract excerpt

<h4>Background: </h4> Injectable interferon-based therapies have been used to treat hepatitis C virus (HCV) infection since 1991. International guidelines have now moved away from interferon-based therapy towards direct-acting antiviral (DAA) tablet regimens, because of their superior efficacy, excellent side-effect profiles, and ease of administration. Initially DAA drugs were prohibitively expensive for most hea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 175a6c61-74d8-515a-a0d4-fab98128fd13
DOI: 10.12688/wellcomeopenres.15408.2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The direct-medical costs associated with interferon-based treatment for Hepatitis C in VietnamDOI 10.12688/wellcomeopenres.15408.2Read

A real world cost effectiveness analysis of interferon-based therapy for HCV naïve super-responders.Semantic proximity Read

Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.Semantic proximity Read

A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in Taiwan.Semantic proximity Read

Cost effectiveness of hepatitis C direct acting agents.Semantic proximity Read

Direct-Acting Antiviral Agents for Patients With Hepatitis C Virus Genotype 1 Infection Are Cost-Saving.Semantic proximity Read

Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in VietnamSemantic proximity Read

Estimated global cost of treating COVID-19, HIV, Hepatitis B and Hepatitis C with approved effective oral medicationsSemantic proximity Read

Treatment and Cost -outcomes of a simplified antiretroviral treatment strategy for hepatitis C among HCV and HIV co-infected patients in UkraineSemantic proximity Read

Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial.Semantic proximity Read

[Cost-effectiveness of chronic hepatitis C treatment in Spain].Semantic proximity Read

Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6.Semantic proximity Read

Cost and cost-effectiveness of Hepatitis C virus self-testing in four settings: an economic evaluationSemantic proximity Read